Ebastine

Ebastine

SCHEMBL2475732

CC(C)(C)c1ccc(C(=O)CCCN2CCC(OC(c3ccccc3)c3ccccc3)CC2)cc1.O=C(O)/C=C/C(=O)O

nearest known ligand 0.91

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

HRH1

The experimentally established mechanism targets of Ebastine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HRH1 known ✓ P35367 1/20 0.91
ADRA1D P25100 2/20 0.91
ADRA1A P35348 2/20 0.91
ADRA1B P35368 2/20 0.91
NPC1 O15118 1/20 0.91
MLNR O43193 1/20 0.91
NR1I2 O75469 1/20 0.91
EGFR P00533 1/20 0.91
LMNA P02545 1/20 0.91
ERBB2 P04626 1/20 0.91
FYN P06241 1/20 0.91
CHRM2 P08172 1/20 0.91
CHRM4 P08173 1/20 0.91
ABCB1 P08183 1/20 0.91
ADRB1 P08588 1/20 0.91
HTR1A P08908 1/20 0.91
CHRM5 P08912 1/20 0.91
ADRA2A P08913 1/20 0.91
ADORA3 P0DMS8 1/20 0.91
CHRM1 P11229 1/20 0.91

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ebastine SCHEMBL28531760 1.00 ADRA1D (0.91) ADRA1DADRA1AADRA1BNPC1MLNR
Ebastine SCHEMBL25199696 1.00 ADRA1D (0.91) ADRA1DADRA1AADRA1BNPC1MLNR
Ebastine SCHEMBL2475734 1.00 ADRA1D (0.91) ADRA1DADRA1AADRA1BNPC1MLNR
Ebastine SCHEMBL25207151 1.00 ADRA1D (0.91) ADRA1DADRA1AADRA1BNPC1MLNR
Ebastine SCHEMBL18467 0.95 ADRA1D (1.00) ADRA1DADRA1AADRA1BNPC1MLNR
Fumaric Acid SCHEMBL10766545 0.95 DRD2 (0.82) ADRA1DADRA1AADRA1BNPC1MLNR
Fumaric Acid SCHEMBL10766542 0.95 DRD2 (0.82) ADRA1DADRA1AADRA1BNPC1MLNR
Ebastine SCHEMBL25205252 0.94 ADRA1D (0.98) ADRA1DADRA1AADRA1BNPC1MLNR
Ebastine SCHEMBL2546560 0.93 ADRA1D (0.96) ADRA1DADRA1AADRA1BNPC1MLNR
SCHEMBL1362953 0.92 ADRA1D (0.94) ADRA1DADRA1AADRA1BNPC1MLNR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112574097-B Preparation method of Ebastine and fumarate thereof 杭州仟源保灵药业有限公司 2023-01-03 CN claimed
CN-112574097-A Preparation method of Ebastine and fumarate thereof 杭州仟源保灵药业有限公司 2021-03-30 CN claimed
WO-2012076919-A1 PROCESS OF PREPARING EBASTINE MICRO LABS LIMITED (IN) 2012-06-14 WO claimed
WO-2009157006-A1 PROCESS OF PREPARING EBASTINE MICRO LABS LIMITED (IN) 2009-12-30 WO claimed
CN-118718873-A A mud prilling granulator for pharmaceutical chemical production 江苏联环药业股份有限公司 2024-10-01 CN disclosed
CN-112574097-B Preparation method of Ebastine and fumarate thereof 杭州仟源保灵药业有限公司 2023-01-03 CN disclosed
CN-112574097-A Preparation method of Ebastine and fumarate thereof 杭州仟源保灵药业有限公司 2021-03-30 CN disclosed
WO-2012076919-A1 PROCESS OF PREPARING EBASTINE MICRO LABS LIMITED (IN) 2012-06-14 WO disclosed
WO-2011121099-A2 PROCESS FOR THE PREPARATION OF 1-[4-(1,1-DIMETHYLETHYL)PHENYL]-4-[4-(DIPHENYLMETHOXY)-1-PIPERIDINYL]-1-BUTANONE AND ACID ADDITION SALTS THEREOF AREVIPHARMA GMBH (DE) 2011-10-06 WO disclosed
EP-2371817-A1 Process for the preparation of 1-[4-(1,1-dimethylethyl)phenyl]-4-[4-(diphenylmethoxy)-1-piperidinyl]-1-butanone and acid addition salts thereof Arevipharma GmbH (DE) 2011-10-05 EP disclosed
WO-2009157006-A1 PROCESS OF PREPARING EBASTINE MICRO LABS LIMITED (IN) 2009-12-30 WO disclosed
EP-0134124-B1 PIPERIDINE DERIVATIVES FORDONAL, S.A. (ES) 1987-10-28 EP disclosed
US-4550116-A ANTIALLERGENS, CARDIOVASCULAR AND RESPIRATORY DISORDERS FORDONAL, S.A. (ES) 1985-10-29 US disclosed
EP-0134124-A1 Piperidine derivatives FORDONAL, S.A. (ES) 1985-03-13 EP disclosed